CipA mediates complement resistance of Acinetobacter baumannii by formation of a Factor I-dependent quadripartite assemblage
Open accessPreprint — published as 10.3389/fimmu.2022.942482
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Multidrug-resistant Acinetobacter baumannii is known to be one of the leading pathogens that cause severe nosocomial infections. To overcome eradication by the innate immune system during infection, A. baumannii developed a number of immune evasion strategies. Previously, we identified CipA as a plasminogen-binding and complement-inhibitory protein. Here we show that CipA strongly inhibits all three complement activation pathways and interacts with key complement components C3, C3b, C4b, C5, Factor B, Factor D, and in particular Factor I. CipA also targets function of the C5 convertase as cleavage of C5 was impaired. Systematic screening of CipA variants identified two separate binding sites for C3b and a Factor I-interacting domain located at the C-terminus. Structure predictions using AlphaFold2 and binding analyses employing CipA variants lacking Factor I-binding capability confirmed that the orientation of the C-terminal domain is essential for the interaction with Factor I. Hence, our analyses point to a novel, Factor I-dependent mechanisms of complement inactivation mediated by CipA of A. baumannii . Recrutiment of Factor I by CipA initiates the assembly of a quadripartite complex following binding of either Factor H or C4b-binding protein to degrade C3b and C4b, respectively. Loss of Factor I binding in a CipA-deficient strain, or a strain producing a CipA variant lacking Factor I-binding capability, correlated with a higher susceptibility to human serum, indicating that recruitment of Factor I enables A. baumannii to resist complement-mediated killing. Significance Statement: The Gram-negative bacterium Acinetobacter baumannii causes severe nosocomial infections and has developed various immune evasion strategies to overcome complement. The mechanisms how Acinetobacter baumannii successfully circumvents complement-mediated bacteriolysis are still poorly understood. Here, we show that the plasminogen-binding and complement inhibitory protein CipA terminates all three complement activation pathways. We describe a novel mechanism by which CipA cleaves the key complement components C3b and C4b in the presence of Factor H and C4b-binding protein by formation of a novel Factor I-dependent quadripartite complex. CipA, which has recently been successfully used for vaccination approaches, might represent an attractive target for the development of novel therapeutic interventions to block disorders with excessive hyperinflammatory complement activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514
SignalP 5.0 improves signal peptide predictions using deep neural networks
Almagro Armenteros, J. J., Tsirigos, K. D., Sønderby, C. K., Petersen, T. N., Winther, O., Brunak, S., von Heijne, G., & Nielsen, H. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0036-z · Cited by 4,284
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Global spread of carbapenem-resistant Acinetobacter baumannii
Higgins, P. G., Dammhayn, C., Hackel, M., & Seifert, H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp428 · Cited by 607
Complement in disease: a defence system turning offensive
Ricklin, D., Reis, E. S., & Lambris, J. D. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.70 · Cited by 550
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
McConnell, M. J., Actis, L., & Pachón, J. (2013) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00344.x · Cited by 540
Ittisoponpisan, S., Islam, S. A., Khanna, T., Alhuzimi, E., David, A., & Sternberg, M. J. E. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.009 · Cited by 489
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases
Rooijakkers, S. H. M., Ruyken, M., Roos, A., Daha, M. R., Presanis, J. S., Sim, R. B., van Wamel, W. J. B., van Kessel, K. P. M., & van Strijp, J. A. G. (2005) · Nature Immunology · doi:10.1038/ni1235 · Cited by 453
Kempf, M., & Rolain, J.-M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.004 · Cited by 389
The Mechanisms of Disease Caused by Acinetobacter baumannii
Morris, F. C., Dexter, C., Kostoulias, X., Uddin, M. I., & Peleg, A. Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01601 · Cited by 360
Kraiczy, P., Skerka, C., Kirschfink, M., Brade, V., & Zipfel, P. F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1674::aid-immu1674>3.0.co;2-2 · Cited by 271
Self-citationStaphylococcal complement evasion by various convertase-blocking molecules
Jongerius, I., Köhl, J., Pandey, M. K., Ruyken, M., van Kessel, K. P. M., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070818 · Cited by 233
Staphylococcus aureus Metalloprotease Aureolysin Cleaves Complement C3 To Mediate Immune Evasion
Laarman, A. J., Ruyken, M., Malone, C. L., van Strijp, J. A. G., Horswill, A. R., & Rooijakkers, S. H. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002948 · Cited by 216
Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
Jacobs, A. C., Hood, I., Boyd, K. L., Olson, P. D., Morrison, J. M., Carson, S., Sayood, K., Iwen, P. C., Skaar, E. P., & Dunman, P. M. (2010) · Infection and Immunity · doi:10.1128/iai.00889-09 · Cited by 214
Valencia, R., Arroyo, L. A., Conde, M., Aldana, J. M., Torres, M.-J., Fernández-Cuenca, F., Garnacho-Montero, J., Cisneros, J. M., Ortiz, C., Pachón, J., et al. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/595977 · Cited by 211
Pfeifer, Y., Wilharm, G., Zander, E., Wichelhaus, T. A., Göttig, S., Hunfeld, K.-P., Seifert, H., Witte, W., & Higgins, P. G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr256 · Cited by 207
Self-citationOuter membrane vesicles as an acellular vaccine against Acinetobacter baumannii
McConnell, M. J., Rumbo, C., Bou, G., & Pachón, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.001 · Cited by 204
Luo, G., Lin, L., Ibrahim, A. S., Baquir, B., Pantapalangkoor, P., Bonomo, R. A., Doi, Y., Adams, M. D., Russo, T. A., & Spellberg, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029446 · Cited by 195
Kim, S. W., Choi, C. H., Moon, D. C., Jin, J. S., Lee, J. H., Shin, J.-H., Kim, J. M., Lee, Y. C., Seol, S. Y., Cho, D. T., et al. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01820.x · Cited by 163
McConnell, M. J., Domínguez-Herrera, J., Smani, Y., López-Rojas, R., Docobo-Pérez, F., & Pachón, J. (2010) · Infection and Immunity · doi:10.1128/iai.00741-10 · Cited by 143
Haupt, K., Reuter, M., van den Elsen, J., Burman, J., Hälbich, S., Richter, J., Skerka, C., & Zipfel, P. F. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000250 · Cited by 141
Fattahian, Y., Rasooli, I., Gargari, S. L. M., Rahbar, M. R., Astaneh, S. D. A., & Amani, J. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.09.004 · Cited by 135
Lee, L. Y. L., Liang, X., Höök, M., & Brown, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408570200 · Cited by 133
Bentancor, L. V., Routray, A., Bozkurt-Guzel, C., Camacho-Peiro, A., Pier, G. B., & Maira-Litrán, T. (2012) · Infection and Immunity · doi:10.1128/iai.06096-11 · Cited by 122
Hair, P. S., Echague, C. G., Sholl, A. M., Watkins, J. A., Geoghegan, J. A., Foster, T. J., & Cunnion, K. M. (2010) · Infection and Immunity · doi:10.1128/iai.01065-09 · Cited by 118
Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D
Stahl, J., Bergmann, H., Göttig, S., Ebersberger, I., & Averhoff, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138360 · Cited by 110
Self-citationHair, P. S., Ward, M. D., Semmes, O. J., Foster, T. J., & Cunnion, K. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/588825 · Cited by 107
CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
Hallström, T., Siegel, C., Mörgelin, M., Kraiczy, P., Skerka, C., & Zipfel, P. F. (2013) · mBio · doi:10.1128/mbio.00481-13 · Cited by 103
Self-citationRusso, T. A., MacDonald, U., Beanan, J. M., Olson, R., MacDonald, I. J., Sauberan, S. L., Luke, N. R., Schultz, L. W., & Umland, T. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/596317 · Cited by 100
Bentancor, L. V., O'Malley, J. M., Bozkurt-Guzel, C., Pier, G. B., & Maira-Litrán, T. (2012) · Infection and Immunity · doi:10.1128/iai.05653-11 · Cited by 99
Detection of pan drug-resistant Acinetobacter baumannii in Germany
Göttig, S., Gruber, T. M., Higgins, P. G., Wachsmuth, M., Seifert, H., & Kempf, V. A. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku170 · Cited by 96
Self-citationStaphylococcal Complement Inhibitor: Structure and Active Sites
Rooijakkers, S. H. M., Milder, F. J., Bardoel, B. W., Ruyken, M., van Strijp, J. A. G., & Gros, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2989 · Cited by 91
Weidensdorfer, M., Ishikawa, M., Hori, K., Linke, D., Djahanschiri, B., Iruegas, R., Ebersberger, I., Riedel-Christ, S., Enders, G., Leukert, L., et al. (2019) · Virulence · doi:10.1080/21505594.2018.1558693 · Cited by 82
Self-citationHallström, T., Trajkovska, E., Forsgren, A., & Riesbeck, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.430 · Cited by 79
Staphylococcus aureus Virulence Is Enhanced by Secreted Factors That Block Innate Immune Defenses
Jongerius, I., von Köckritz‐Blickwede, M., Horsburgh, M. J., Ruyken, M., Nizet, V., & Rooijakkers, S. H. M. (2012) · Journal of Innate Immunity · doi:10.1159/000334604 · Cited by 74
Badmasti, F., Ajdary, S., Bouzari, S., Fooladi, A. A. I., Shahcheraghi, F., & Siadat, S. D. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.031 · Cited by 68
King, L. B., Pangburn, M. K., & McDaniel, L. S. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis939 · Cited by 67
BBA70 of Borrelia burgdorferi Is a Novel Plasminogen-binding Protein
Koenigs, A., Hammerschmidt, C., Jutras, B. L., Pogoryelov, D., Barthel, D., Skerka, C., Kugelstadt, D., Wallich, R., Stevenson, B., Zipfel, P. F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413872 · Cited by 67
Self-citationHammerschmidt, C., Klevenhaus, Y., Koenigs, A., Hallström, T., Fingerle, V., Skerka, C., Pos, K. M., Zipfel, P. F., Wallich, R., & Kraiczy, P. (2015) · Molecular Microbiology · doi:10.1111/mmi.13239 · Cited by 66
Self-citationHourcade, D. E., Mitchell, L. M., Kuttner-Kondo, L. A., Atkinson, J. P., & Medof, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109322200 · Cited by 65
Del Tordello, E., Vacca, I., Ram, S., Rappuoli, R., & Serruto, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321556111 · Cited by 65
Hammerschmidt, C., Koenigs, A., Siegel, C., Hallström, T., Skerka, C., Wallich, R., Zipfel, P. F., & Kraiczy, P. (2013) · Infection and Immunity · doi:10.1128/iai.01094-13 · Cited by 63
Self-citationCunnion, K. M., Hair, P. S., & Buescher, E. S. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.2858-2863.2004 · Cited by 62
Leishmania: Overexpression and Comparative Structural Analysis of the Stage-Regulated Meta 1 Gene
Uliana, S. R. B., Goyal, N., Freymüller, E. H., & Smith, D. F. (1999) · Experimental Parasitology · doi:10.1006/expr.1999.4410 · Cited by 61
Liu, D., Liu, Z., Hu, P., Cai, L., Fu, B., Li, Y., Lu, S., Liu, N., Ma, X., Chi, D., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.02.018 · Cited by 59
Dasari, P., Nordengrün, M., Vilhena, C., Steil, L., Abdurrahman, G., Surmann, K., Dhople, V. M., Lahrberg, J., Bachert, C., Skerka, C., et al. (2021) · Journal of Bacteriology · doi:10.1128/jb.00184-21 · Cited by 54
CipA ofAcinetobacter baumanniiIs a Novel Plasminogen Binding and Complement Inhibitory Protein
Koenigs, A., Stahl, J., Averhoff, B., Göttig, S., Wichelhaus, T. A., Wallich, R., Zipfel, P. F., & Kraiczy, P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv601 · Cited by 51
Self-citationRicklin, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.016 · Cited by 49
Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein
Koenigs, A., Zipfel, P. F., & Kraiczy, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134418 · Cited by 45
Self-citationThe Catalytically Active Serine Protease Domain of Human Complement Factor I
Tsiftsoglou, S. A., Willis, A. C., Li, P., Chen, X., Mitchell, D. A., Rao, Z., & Sim, R. B. (2005) · Biochemistry · doi:10.1021/bi047680t · Cited by 44
Convertase Inhibitory Properties of Staphylococcal Extracellular Complement-binding Protein
Jongerius, I., Garcia, B. L., Geisbrecht, B. V., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091975 · Cited by 44
Luo, S., Dasari, P., Reiher, N., Hartmann, A., Jacksch, S., Wende, E., Barz, D., Niemiec, M. J., Jacobsen, I. D., Beyersdorf, N., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.07.010 · Cited by 43
Lötsch, F., Albiger, B., Monnet, D. L., Struelens, M. J., Seifert, H., Kohlenberg, A., & European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) carbapenem-resistant Acinetobacter baumannii capacity survey group (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.45.2001735 · Cited by 39
Elucidating the Immune Evasion Mechanisms of Borrelia mayonii, the Causative Agent of Lyme Disease
Walter, L. I., Sürth, V., Röttgerding, F., Zipfel, P. F., Fritz‐Wolf, K., & Kraiczy, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02722 · Cited by 34
Self-citationBolourchi, N., Shahcheraghi, F., Shirazi, A. S., Janani, A., Bahrami, F., & Badmasti, F. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.03.031 · Cited by 27
Malm, S., Jusko, M., Eick, S., Potempa, J., Riesbeck, K., & Blom, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034852 · Cited by 26
Mendes‐Sousa, A. F., do Vale, V. F., Silva, N. C. S., Guimarães-Costa, A. B., Pereira, M. H., Sant'Anna, M. R. V., Oliveira, F., Kamhawi, S., Ribeiro, J. M. C., Andersen, J. F., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01065 · Cited by 26
Serum complement factor I decreases Staphylococcus aureus phagocytosis
Cunnion, K. M., Buescher, E. S., & Hair, P. S. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.07.001 · Cited by 23
Tietgen, M., Kramer, J. S., Brunst, S., Djahanschiri, B., Wohra, S., Higgins, P. G., Weidensdorfer, M., Riedel-Christ, S., Pos, K. M., Gonzaga, A., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz080 · Cited by 16
Self-citationBadmasti, F., Habibi, M., Firoozeh, F., Fereshteh, S., Bolourchi, N., & Goodarzi, N. N. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105063 · Cited by 12
Kraiczy, P., Schreiber, J., Skerka, C., Haupt, K., Brade, V., Wallich, R., & Zipfel, P. F. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.12.008 · Cited by 5
Self-citation
Research works printed but not linked: 2
- 10.1016/S1473-3099(17)30753-191 · doi:10.1016/s1473-3099(17)30753-191
- 10.21203/rs.3.rs-1032816/v1 · doi:10.21203/rs.3.rs-1032816/v1
Metadata
- Authors
- Ries, J. I., Heß, M., Nouri, N., Wichelhaus, T. A., Göttig, S., Falcone, F. H., & Kraiczy, P.
- Affiliations
- Goethe University Frankfurt (DE)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Kraiczy, Peter
- Venue
- Frontiers in Immunology
- Publisher
- openRxiv
- Published
- 2022-02-17
- Volume
- 13
- Pages
- 942482-942482
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9361855
- OpenAlex
- W4288038175
- Cited by
- 17
- References
- 66
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 2
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- Acinetobacter baumannii, CIPA, complement resistance, complement inactivation, factor I, C3b, C4b, C5 convertase, plasminogen-binding protein, immune evasion, complement factor H, C4b-binding protein, multidrug resistance, nosocomial infections, protein-protein interaction
- MeSH terms
- Complement Activation, Fibrinogen, Humans, Complement Factor B, Acinetobacter baumannii, Complement C3-C5 Convertases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.